259 related articles for article (PubMed ID: 18314200)
1. Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review.
Sharma V; Khan M; Corpse C
J Affect Disord; 2008 Nov; 111(1):100-5. PubMed ID: 18314200
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine for the treatment of bipolar spectrum disorder: a chart review.
Montes JM; Saiz-Ruiz J; Lahera G; Asiel A
J Affect Disord; 2005 May; 86(1):69-73. PubMed ID: 15820272
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers.
Chang JS; Moon E; Cha B; Ha K
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1322-6. PubMed ID: 20673782
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression.
Ahn YM; Nam JY; Culver JL; Marsh WK; Bonner JC; Ketter TA
Ann Clin Psychiatry; 2011 Feb; 23(1):17-24. PubMed ID: 21318192
[TBL] [Abstract][Full Text] [Related]
5. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
[TBL] [Abstract][Full Text] [Related]
6. Identification of bipolar disorder in women with postpartum depression.
Sharma V; Khan M
Bipolar Disord; 2010 May; 12(3):335-40. PubMed ID: 20565441
[TBL] [Abstract][Full Text] [Related]
7. Lamotrigine: a depression mood stabiliser.
Herman E
Eur Neuropsychopharmacol; 2004 May; 14 Suppl 2():S89-93. PubMed ID: 15142613
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.
Calabrese JR; Huffman RF; White RL; Edwards S; Thompson TR; Ascher JA; Monaghan ET; Leadbetter RA
Bipolar Disord; 2008 Mar; 10(2):323-33. PubMed ID: 18271912
[TBL] [Abstract][Full Text] [Related]
9. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
10. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study.
Bramness JG; Grøholt B; Engeland A; Furu K
J Affect Disord; 2009 Oct; 117(3):208-11. PubMed ID: 19189871
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of lamotrigine in bipolar disorder in a clinical setting.
Ketter TA; Brooks JO; Hoblyn JC; Champion LM; Nam JY; Culver JL; Marsh WK; Bonner JC
J Psychiatr Res; 2008 Nov; 43(1):13-23. PubMed ID: 18423667
[TBL] [Abstract][Full Text] [Related]
12. Typical neuroleptics vs. atypical antipsychotics in the treatment of acute mania in a natural setting.
Letmaier M; Schreinzer D; Reinfried L; Glauninger G; Thierry N; Kapitany T; Kasper S
Int J Neuropsychopharmacol; 2006 Oct; 9(5):529-37. PubMed ID: 16191207
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
[TBL] [Abstract][Full Text] [Related]
14. Observational study to evaluate the clinical benefit of lamotrigine add-on therapy in bipolar patients in a naturalistic treatment setting.
Woo YS; Bahk WM; Pae CU; Jeong JH; Koo BH; Jon DI; Lee JG; Kim MD
Asia Pac Psychiatry; 2014 Sep; 6(3):334-41. PubMed ID: 24038834
[TBL] [Abstract][Full Text] [Related]
15. A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive.
Glick ID; Bosch J; Casey DE
J Clin Psychopharmacol; 2009 Jun; 29(3):267-71. PubMed ID: 19440081
[TBL] [Abstract][Full Text] [Related]
16. Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament.
Manning JS; Haykal RF; Connor PD; Cunningham PD; Jackson WC; Long S
J Affect Disord; 2005 Feb; 84(2-3):259-66. PubMed ID: 15708424
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states.
Perugi G; Toni C; Ruffolo G; Sartini S; Simonini E; Akiskal H
Pharmacopsychiatry; 1999 Jul; 32(4):136-41. PubMed ID: 10505483
[TBL] [Abstract][Full Text] [Related]
18. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine (Lamictal IR) for the treatment of bipolar disorder.
Bowden CL; Singh V
Expert Opin Pharmacother; 2012 Dec; 13(17):2565-71. PubMed ID: 23140205
[TBL] [Abstract][Full Text] [Related]
20. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
Shajahan P; Taylor M
J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
